|
|
Blood, 15 September 2007, Vol. 110, No. 6, pp. 1970-1981.
Prepublished online as a Blood First Edition Paper on June 4, 2007; DOI 10.1182/blood-2006-09-044776.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Stanimir Ivanov1,
Ana-Maria Dragoi1,
Xin Wang1,
Corrado Dallacosta2,
Jennifer Louten1,
Giovanna Musco2,
Giovanni Sitia2,
George S. Yap1,
Yinsheng Wan3,
Christine A. Biron1,
Marco E. Bianchi4,
Haichao Wang5, and
Wen-Ming Chu1
1 Department of Molecular Microbiology and Immunology, Brown University, Providence, RI;
2 San Raffaele Scientific Institute, Milano, Italy;
3 Department of Biology, Providence College, Providence, RI;
4 San Raffaele University, Faculty of Medicine, Milano, Italy;
5 Department of Emergency Medicine, North Shore-Long Island Jewish Research Institute, Manhasset, NY
CpG-DNA or its synthetic analog CpG-ODN activates innate immunity through Toll-like receptor 9 (TLR9). However, the mechanism of TLR9 activation by CpG-DNA remains elusive. Here we have identified HMGB1 as a CpG-ODN–binding protein. HMGB1 interacts and preassociates with TLR9 in the endoplasmic reticulum-Golgi intermediate compartment (ERGIC), and hastens TLR9's redistribution to early endosomes in response to CpG-ODN. CpG-ODN stimulates macrophages and dendritic cells to secrete HMGB1; in turn, extracellular HMGB1 accelerates the delivery of CpG-ODNs to its receptor, leading to a TLR9-dependent augmentation of IL-6, IL-12, and TNF secretion. Loss of HMGB1 leads to a defect in the IL-6, IL-12, TNF , and iNOS response to CpG-ODN. However, lack of intracellular TLR9-associated HMGB1 can be compensated by extracellular HMGB1. Thus, the DNA-binding protein HMGB1 shuttles in and out of immune cells and regulates inflammatory responses to CpG-DNA.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Tang, R. Kang, W. Xiao, H. Zhang, M. T. Lotze, H. Wang, and X. Xiao
Quercetin Prevents LPS-Induced High-Mobility Group Box 1 Release and Proinflammatory Function
Am. J. Respir. Cell Mol. Biol.,
December 1, 2009;
41(6):
651 - 660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Qin, S.-M. Dai, G.-S. Tang, J. Zhang, D. Ren, Z.-W. Wang, and Q. Shen
HMGB1 Enhances the Proinflammatory Activity of Lipopolysaccharide by Promoting the Phosphorylation of MAPK p38 through Receptor for Advanced Glycation End Products
J. Immunol.,
November 15, 2009;
183(10):
6244 - 6250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Palumbo, F. De Marchis, T. Pusterla, A. Conti, M. Alessio, and M. E. Bianchi
Src family kinases are necessary for cell migration induced by extracellular HMGB1
J. Leukoc. Biol.,
September 1, 2009;
86(3):
617 - 623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Hreggvidsdottir, T. Ostberg, H. Wahamaa, H. Schierbeck, A.-C. Aveberger, L. Klevenvall, K. Palmblad, L. Ottosson, U. Andersson, and H. E. Harris
The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation
J. Leukoc. Biol.,
September 1, 2009;
86(3):
655 - 662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yao, X. Liu, D. Li, T. Chen, Z. Cai, and X. Cao
Late Endosome/Lysosome-Localized Rab7b Suppresses TLR9-Initiated Proinflammatory Cytokine and Type I IFN Production in Macrophages
J. Immunol.,
August 1, 2009;
183(3):
1751 - 1758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Urbonaviciute, B. G. Furnrohr, S. Meister, L. Munoz, P. Heyder, F. De Marchis, M. E. Bianchi, C. Kirschning, H. Wagner, A. A. Manfredi, et al.
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE
J. Exp. Med.,
December 22, 2008;
205(13):
3007 - 3018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Uccellini, L. Busconi, N. M. Green, P. Busto, S. R. Christensen, M. J. Shlomchik, A. Marshak-Rothstein, and G. A. Viglianti
Autoreactive B Cells Discriminate CpG-Rich and CpG-Poor DNA and This Response Is Modulated by IFN-{alpha}
J. Immunol.,
November 1, 2008;
181(9):
5875 - 5884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Re and J. L. Cook
The physiological basis of intracrine stem cell regulation
Am J Physiol Heart Circ Physiol,
August 1, 2008;
295(2):
H447 - H453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chorny, P. Anderson, E. Gonzalez-Rey, and M. Delgado
Ghrelin Protects against Experimental Sepsis by Inhibiting High-Mobility Group Box 1 Release and by Killing Bacteria
J. Immunol.,
June 15, 2008;
180(12):
8369 - 8377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Youn, Y. J. Oh, E. S. Kim, J. E. Choi, and J.-S. Shin
High Mobility Group Box 1 Protein Binding to Lipopolysaccharide Facilitates Transfer of Lipopolysaccharide to CD14 and Enhances Lipopolysaccharide-Mediated TNF-{alpha} Production in Human Monocytes
J. Immunol.,
April 1, 2008;
180(7):
5067 - 5074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Re and J. L. Cook
The Basis of an Intracrine Pharmacology
J. Clin. Pharmacol.,
March 1, 2008;
48(3):
344 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|